Cargando…
Selective ablation of TRA-1-60(+) pluripotent stem cells suppresses tumor growth of prostate cancer
Purpose: TRA-1-60 (TRA) is an established transcription factor of embryonic signaling and a well-known marker of pluripotency. It has been implicated in tumorigenesis and metastases, is not expressed in differentiated cells, which makes it an appealing biomarker for immunopositron emission tomograph...
Autores principales: | White, Jordan M., Ramos, Nicholas, Saliganan, Allen-Dexter, Chung, Joon-Yong, Bell, Meghan, Lindquist, Jacob, Conner, Kayla, Wiesend, Wendy N., Schopperle, Michael, Patrick, Steve M., Kim, Seongho, Heath, Elisabeth I., Escorcia, Freddy E., Viola, Nerissa T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157726/ https://www.ncbi.nlm.nih.gov/pubmed/37153742 http://dx.doi.org/10.7150/thno.78915 |
Ejemplares similares
-
Perspectives on metals-based radioimmunotherapy (RIT): moving forward
por: White, Jordan M., et al.
Publicado: (2021) -
TRA-1-60-positive/CD45(low) cells found in the peripheral blood of prostate cancer patients with metastatic disease – A proof-of-concept study
por: Schäfer, Claudia, et al.
Publicado: (2020) -
Identification of TRA‐1‐60‐positive cells as a potent refractory population in follicular lymphomas
por: Takata, Katsuyoshi, et al.
Publicado: (2018) -
Association with the nonparoxysmal atrial fibrillation duration and outcome of ExTRa Mapping‐guided rotor ablation
por: Okuyama, Yusuke, et al.
Publicado: (2023) -
Le tra{circ}itre
por: Gorz, André
Publicado: (1958)